These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33422298)

  • 1. Complete but transient clinical remission of vulvar Paget's disease with paclitaxel and trastuzumab.
    Isnard C; Plantier F; Thériaut M; Avril MF; Moyal-Barracco M
    Ann Dermatol Venereol; 2021 Mar; 148(1):47-48. PubMed ID: 33422298
    [No Abstract]   [Full Text] [Related]  

  • 2. Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulva.
    Bartoletti M; Mazzeo R; De Scordilli M; Del Fabro A; Vitale MG; Bortot L; Nicoloso MS; Corsetti S; Bonotto M; Scalone S; Giorda G; Sorio R; Andreetta C; Meacci ML; De Vivo R; Fasola G; Sopracordevole F; Puglisi F
    Int J Gynecol Cancer; 2020 Nov; 30(11):1672-1677. PubMed ID: 32998859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic Extramammary Paget's Disease with near-complete response to trastuzumab and paclitaxel therapy.
    Dao A; Chung AD; Gray G
    Arch Gynecol Obstet; 2024 Jul; 310(1):595-597. PubMed ID: 38494513
    [No Abstract]   [Full Text] [Related]  

  • 4. Imiquimod in vulvar Paget's disease: a case report.
    Geisler JP; Manahan KJ
    J Reprod Med; 2008 Oct; 53(10):811-2. PubMed ID: 19004411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HER-2/neu targeting for recurrent vulvar Paget's disease A case report and literature review.
    Karam A; Berek JS; Stenson A; Rao J; Dorigo O
    Gynecol Oncol; 2008 Dec; 111(3):568-71. PubMed ID: 18252264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experiences of trastuzumab plus paclitaxel combination therapy in metastatic human epidermal growth factor receptor 2-positive extramammary Paget's disease: Four cases and a review.
    Sekiguchi N; Kubota S; Noguchi T; Fukushima T; Kobayashi T; Kanda S; Koizumi T; Miyake T; Shirai T; Okuyama R
    J Dermatol; 2020 Nov; 47(11):1276-1279. PubMed ID: 32706146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of a vulvar Paget's disease by photodynamic therapy with a new light emitting fabric based device.
    Vicentini C; Carpentier O; Lecomte F; Thecua E; Mortier L; Mordon SR
    Lasers Surg Med; 2017 Feb; 49(2):177-180. PubMed ID: 28103628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerance of photodynamic therapy for vulvar Paget's disease: a multicentric retrospective study.
    Rioli DI; Samimi M; Beneton N; Hainaut E; Martin L; Misery L; Quereux G
    Eur J Dermatol; 2018 Jun; 28(3):351-355. PubMed ID: 29976540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of trastuzumab in HER-2-positive advanced extramammary Paget's disease.
    Zhu H; Lewis DJ
    Expert Opin Biol Ther; 2022 May; 22(5):673-674. PubMed ID: 35414305
    [No Abstract]   [Full Text] [Related]  

  • 10. Photodynamic therapy following fractional CO
    Ferrara F; Bardazzi F; Messori S; Abbenante D; Barisani A; Vaccari S
    J Dermatolog Treat; 2021 Nov; 32(7):800-802. PubMed ID: 31858840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methyl - aminolevulinic acid photodynamic therapy and topical tretinoin in a patient with vulvar extramammary Paget's disease.
    Magnano M; Loi C; Bardazzi F; Burtica EC; Patrizi A
    Dermatol Ther; 2013; 26(2):170-2. PubMed ID: 23551374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical treatment of vulvar Paget's disease: a case report.
    Anton C; Luiz AV; Carvalho FM; Baracat EC; Carvalho JP
    Clinics (Sao Paulo); 2011; 66(6):1109-11. PubMed ID: 21808885
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of imiquimod on vulvar Paget's disease: a systematic review of literature.
    Machida H; Moeini A; Roman LD; Matsuo K
    Gynecol Oncol; 2015 Oct; 139(1):165-71. PubMed ID: 26193428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidisciplinary treatment of vulval extramammary Paget's disease to maintain sexual function: an imiquimod success story.
    Challenor R; Hughes G; Fitton AR
    J Obstet Gynaecol; 2009 Apr; 29(3):252-4. PubMed ID: 19358042
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of recurrent Paget's disease of the vulva with topical bleomycin.
    Watring WG; Roberts JA; Lagasse LD; Berman ML; Ballon SC; Moore JG; Schlesinger RE
    Cancer; 1978 Jan; 41(1):10-1. PubMed ID: 75051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of recurrent extramammary Paget's disease of the vulva with topical imiquimod 5% cream.
    Wang LC; Blanchard A; Judge DE; Lorincz AA; Medenica MM; Busbey S
    J Am Acad Dermatol; 2003 Oct; 49(4):769-72. PubMed ID: 14512941
    [No Abstract]   [Full Text] [Related]  

  • 17. Photodynamic therapy for inoperable vulval Paget's disease using delta-aminolaevulinic acid: successful management of a large skin lesion.
    Henta T; Itoh Y; Kobayashi M; Ninomiya Y; Ishibashi A
    Br J Dermatol; 1999 Aug; 141(2):347-9. PubMed ID: 10468815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammary and extramammary Paget's disease.
    Lloyd J; Flanagan AM
    J Clin Pathol; 2000 Oct; 53(10):742-9. PubMed ID: 11064666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of three cases of primary extramammary Paget's disease of the vulva with Imiquimod--proposal of a therapeutic schedule.
    Sendagorta E; Herranz P; Feito M; Ramírez P; Floristán U; Feltes R; Benito DM; Casado M
    J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):490-2. PubMed ID: 19840203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete response of extramammary Paget's disease with imiquimod and PDT: Report of two cases.
    Apalla Z; Lallas A; Tsorova A; Nikolaidou C; Vakirlis E; Ioannides D; Sotiriou E
    Photodermatol Photoimmunol Photomed; 2018 Jul; 34(4):273-275. PubMed ID: 29575126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.